Hillary Clinton accused Pfizer of using legal loopholes to avoid its "fair share" of taxes.» Read More
Stocks ended lower for a second straight session in light volume as the glow from housing starts faded and banks skidded.
I have a confession to make. I try to be as transparent as possible, to share as much information as I can about how the sausage is made. To that end, on at least a few occasions I’ve mentioned on this blog and on CNBC, that I’ve been on 10 milligrams of Lipitor.
On a week where oil topped $73 per barrel for the first time in 8 months before receding on Friday, treasury auctions moved the equity market, and GM and Citi were replaced in the Dow, the markets are flat to positive on the week, but the Dow manages to go positive year-to-date.
The judge threw the book at the man, but at the same time he didn't sentence him by the book. Andrew Bodnar pleaded guilty to his role in the generic Plavix brouhaha a couple of years ago. And yesterday a District Court judge fined him $5,000 and ordered Bodnar to write a book about what happened. Write a book!
Today, Cisco and Travelers replaced Citigroup and GM on the Dow. Here is a look back at the previous 10 changes to the Dow and what happened to the benchmark in the days leading up to and following the change.
With stocks rallying for over 3 months now, dividend yields continue to fall back to Earth. Today, two new components join the Dow, one with a dividend and one without. See how the 30 companies in the Dow compare.
Cramer makes the call on viewers' favorite stocks.
In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.
How much higher do we need to go before the bears believe this rally is real?
The cost of drugs was a hot topic at ASCO this year, especially with the release of the big test results combining two very expensive treatments for lung cancer. The study showed using Avastin from Roche and Genentech and a pill, Tarceva, from OSI Pharmaceuticals, Roche and Genentech slowed down progression of the disease by a little more than a month.
The Dow Industrials briefly turned positive for the year earlier this morning. WAHOO! But wait…the S&P 500 turned positive for 2009 nearly one month ago and is now up over 4.5% this year. So why the performance lag in the Dow (compared to the S&P)?
With the exit of Citigroup and GM from the Dow, new comers Cisco and Travelers bring some heft back into the index. As of Monday's close, the price weighted index is taking out $4.44 (combined price of Citi and GM) and adding in $61.41 (CSCO + TRV). Here's how this change will impact the weight of the remaining 28 stocks of the Dow.
We are putting cash back to work, said Ron Muhlenkamp, portfolio manager at The Muhlenkamp Fund, and Jeff Mortimer, CIO of Charles Schwab Investment Management.
How will male General Motors retirees get their motor runnin'? Do they start paying for their impotence drugs out of their own pocket? Because apparently, under the new deal the company won't pick up the tab anymore.
Consumers may be saving more and spending less, but big pharma is on a shopping spree. And I'm not talking about the really big deals including Roche buying Genentech, Pfizer buying Wyeth and Merck buying Schering-Plough. I'm talking about the two deals that have been done in less than a week between major drug companies and baby biotechs specializing in oncology.
One year after urging regulators to guide Lehman Brothers toward a recapitalization and recognition of its losses, hedge fund manager David Einhorn is making more potentially prescient speeches—this time about ratings agencies and gold.
Plus, Cramer explains why First Niagara is just the type of bank that investors want right now.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Hewlett Packard reported earnings after the bell yesterday, and met analyst expectations. All 30 Dow stocks have now reported -- here is a summary of how the season stacked up.
Kirk Kerkorian and Warren Buffett are two more of the world’s richest investors who have just revealed how they’re gaming stocks!